Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Interlune is a lunar resource harvesting company focused on the extraction and transportation of materials from the Moon for use on Earth. The company's primary initial objective is the commercial-scale harvesting of Helium-3, a rare isotope with critical applications in quantum computing, fusion energy, and medical diagnostics. In the healthcare sector, Helium-3 is utilized as a contrast agent for hyperpolarized gas MRI, enabling high-resolution, functional imaging of the lungs to diagnose conditions like chronic obstructive pulmonary disease (COPD) and asthma. Founded by aerospace veterans from Blue Origin and an Apollo 17 astronaut, Interlune is developing proprietary technology to identify and extract these resources sustainably. The company aims to alleviate the global shortage of Helium-3 by establishing a reliable supply chain from the lunar surface to support next-generation medical imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interlune.